Garvagliptin
Garvagliptin (ZYDPLA1) is an orally active, competitive and long acting DPP4 Inhibitor, with an IC50 of 2.99 nM against human recombinant DPP IV. Garvagliptin (ZYDPLA1) exhibits antihyperglycemic effect.
For research use only. We do not sell to patients.
- CAS No.: 1601479-87-1
- Formula: C18H23F2N3O3S
- Molecular Weight:399.46
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 1601479-87-1
-
Molecular Weight 399.46
-
Formula C18H23F2N3O3S
-
SMILES
CS(=O)(N1CC2=C(C1)CN([C@@H]3C[C@@H]([C@@H](C4=C(C=CC(F)=C4)F)OC3)N)C2)=O
-
Synonyms
ZYDPLA1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Garvagliptin Related Classifications
HY-109060 Related Classifications
Powered by Bioz